Avantor, Inc. (AVTR) Stock Price

AVTRStock

$14.42+7.46%52W

Market Cap$9.75B

P/E—

PEG Ratio—

Div yield—

Beta0.95

AVTR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)42.58%

Price vs S&P 500 (4W)11.76%

VGM Score54.44

P/CF (Annual)14.98x

Book Value / Share (Quarterly)$8.32

P/TBV (Annual)3.30x

Revenue Growth (3Y)-4.46%

Cash Flow / Share (Quarterly)$0.67

Price vs S&P 500 (YTD)12.47%

Gross Margin (TTM)31.83%

Net Profit Margin (TTM)-8.81%

EPS (TTM)$-0.85

10-Day Avg Trading Volume5.94M

EPS Excl Extra (TTM)$-0.85

Revenue Growth (5Y)0.49%

EPS (Annual)$-0.78

Dividend / Share (Annual)$0.00

ROI (Annual)-5.57%

Gross Margin (Annual)32.65%

Net Profit Margin (5Y Avg)4.78%

Cash / Share (Quarterly)$0.45

Revenue Growth QoQ (YoY)0.53%

ROA (Last FY)-4.50%

Revenue Growth TTM (YoY)-1.57%

EBITD / Share (TTM)$0.16

ROE (5Y Avg)7.26%

Operating Margin (TTM)-4.68%

Cash Flow / Share (Annual)$0.73

P/B Ratio1.66x

P/B Ratio (Quarterly)1.20x

Net Income / Employee (Annual)$-39,300

EV / Revenue (TTM)1.94x

Net Interest Coverage (TTM)-1.49x

ROA (TTM)-4.95%

EPS Growth QoQ (YoY)-40.67%

EV / EBITDA (TTM)114.24x

EPS Incl Extra (Annual)$-0.78

Current Ratio (Annual)1.78x

Quick Ratio (Quarterly)1.18x

3-Month Avg Trading Volume9.97M

52-Week Price Return7.46%

EV / Free Cash Flow (Annual)25.73x

Revenue / Employee (TTM)$486,000

Tangible BV / Share (Quarterly)$3.87

P/S Ratio (Annual)1.43x

Asset Turnover (Annual)0.56x

52-Week High$15.93

Operating Margin (5Y Avg)9.95%

EPS Excl Extra (Annual)$-0.78

CapEx CAGR (5Y)15.90%

26-Week Price Return53.83%

Quick Ratio (Annual)1.18x

13-Week Price Return81.19%

Total Debt / Equity (Annual)0.71x

Current Ratio (Quarterly)1.78x

Enterprise Value$12.74B

Revenue / Share Growth (5Y)-2.56%

Asset Turnover (TTM)0.56x

Book Value / Share Growth (5Y)12.09%

Revenue / Employee (Annual)$485,300

Inventory Turnover (Annual)5.70x

Pretax Margin (Annual)-6.74%

Cash / Share (Annual)$0.54

3-Month Return Std Dev53.90%

Gross Margin (5Y Avg)33.74%

Net Income / Employee (TTM)$-42,800

EBITDA Interim CAGR (5Y)-7.65%

ROE (Last FY)-9.53%

Net Interest Coverage (Annual)-1.82x

EPS Basic Excl Extra (Annual)$-0.78

P/FCF (TTM)20.56x

Receivables Turnover (TTM)5.73x

EV / Free Cash Flow (TTM)28.01x

Total Debt / Equity (Quarterly)0.66x

EPS Incl Extra (TTM)$-0.85

Receivables Turnover (Annual)6.21x

ROI (TTM)-6.14%

P/S Ratio (TTM)1.42x

Pretax Margin (5Y Avg)6.65%

Revenue / Share (Annual)$9.63

Tangible BV / Share (Annual)$3.48

Forward P/E17.76x

Free OCF CAGR (5Y)-10.63%

Price vs S&P 500 (52W)-10.85%

Year-to-Date Return24.43%

5-Day Price Return6.98%

EPS Normalized (Annual)$-0.78

ROA (5Y Avg)2.61%

Net Profit Margin (Annual)-8.09%

Month-to-Date Return3.48%

Cash Flow / Share (TTM)$1.13

EBITD / Share (Annual)$-0.36

Operating Margin (Annual)-3.83%

LT Debt / Equity (Annual)0.70x

P/CF (TTM)15.66x

ROI (5Y Avg)3.16%

LT Debt / Equity (Quarterly)0.65x

EPS Basic Excl Extra (TTM)$-0.85

P/TBV (Quarterly)2.58x

P/B Ratio (Annual)1.40x

Inventory Turnover (TTM)5.56x

Pretax Margin (TTM)-7.19%

Book Value / Share (Annual)$8.16

Price vs S&P 500 (13W)78.40%

Beta0.95x

P/FCF (Annual)18.88x

Revenue / Share (TTM)$9.69

ROE (TTM)-10.34%

52-Week Low$7.26

vGradeB

gGradeF

mGradeA

vgmGradeC

AVTR Earnings Surprise History

Q2 250.24est. 0.25

Q3 250.22est. 0.23

Q4 250.22est. 0.22

Q1 260.17est. 0.16

Q2 260.21est. 0.19

AVTR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

2.79

3.32

2.76

3.40

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
AVTRAvantor, Inc.	B	F	A	$14.42
AAgilent Technologies Inc.	D	C	B	$154.77
WATWaters Corp	D	C	B	$414.44
ILMNIllumina Inc	D	D	A	$224.99
MTDMettler-Toledo International	D	C	B	$1402.25
RVTYRevvity, Inc.	C	D	B	$124.84
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$390.34
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
BRKRBruker Corporation	D	D	B	$56.85
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$64.72
ALMRAlamar Biosciences, Inc. Common Stock	—	—	A	$33.02
CTKBCytek Biosciences, Inc. Common Stock	C	C	C	$4.58
PACBPacific Biosciences of California, Inc.	D	C	C	$1.52
MASS908 Devices Inc. Common Stock	C	C	A	$11.00
EYPTEyePoint, Inc. Common Stock	D	F	F	$5.00
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$23.25
LABStandard BioTools Inc. Common Stock	A	F	D	$0.65
QTRXQuanterix Corporation Common Stock	A	C	C	$2.79
SEERSeer, Inc. Class A Common Stock	C	D	C	$2.04
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.88
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.66
PRPOPrecipio, Inc. Common Stock	C	A	A	$30.85
HBIOHarvard Bioscience Inc	B	F	A	$7.58
ASTCAstrotech Corporation (DE) Common Stock	C	C	A	$7.10
BNGOBionano Genomics, Inc. Common Stock	A	C	C	$1.25
HLTHTema Healthcare AI ETF	—	F	D	$29.92
PRENWPrenetics Global Limited Warrant	—	—	D	$0.01

About Avantor, Inc.

Avantor supplies essential laboratory products, equipment, and services to life sciences, healthcare, and advanced materials industries globally. The company operates two segments—Laboratory Solutions and Bioscience Production—offering high-purity chemicals, reagents, lab consumables, chromatography products, and specialized procurement services. Its portfolio serves biopharma, healthcare, government, and advanced technology customers across the Americas, Europe, and AMEA.